Laboratorios Farmaceuticos Rovi (MEX:ROVIN) E10: MXN49.10 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ROVIN Laboratorios Farmaceuticos Rovi SA MEX:ROVIN
81 GF Score
Price MXN1,168.82
GF Value MXN1,103.32
! 2 Warning Signs
View Full Analysis

What is Laboratorios Farmaceuticos Rovi E10?

Laboratorios Farmaceuticos Rovi MEX:ROVIN 81 E10 is MXN49.10 as of Jun. 2026. GuruFocus rates MEX:ROVIN with a GF Score™ of 81/100 and a GF Value™ of MXN1,103.32. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Laboratorios Farmaceuticos Rovi's adjusted earnings per share data for the three months ended in Jun. 2026 was MXN29.479. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN49.10 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Laboratorios Farmaceuticos Rovi's average E10 Growth Rate was 16.90% per year. During the past 3 years, the average E10 Growth Rate was 24.00% per year. During the past 5 years, the average E10 Growth Rate was 33.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Laboratorios Farmaceuticos Rovi was 43.30% per year. The lowest was 21.30% per year. And the median was 34.20% per year.

As of today (2026-08-09), Laboratorios Farmaceuticos Rovi's current stock price is MXN1168.82. Laboratorios Farmaceuticos Rovi's E10 for the quarter that ended in Jun. 2026 was MXN49.10. Laboratorios Farmaceuticos Rovi's Shiller PE Ratio of today is 23.80.

During the past 13 years, the highest Shiller PE Ratio of Laboratorios Farmaceuticos Rovi was 105.81. The lowest was 22.38. And the median was 43.60.


Laboratorios Farmaceuticos Rovi  (MEX:ROVIN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Laboratorios Farmaceuticos Rovi's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1168.82/49.10
=23.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Laboratorios Farmaceuticos Rovi was 105.81. The lowest was 22.38. And the median was 43.60.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Laboratorios Farmaceuticos Rovi E10 Related Terms


Laboratorios Farmaceuticos Rovi E10 Historical Data

* Premium members only.

The historical data trend for Laboratorios Farmaceuticos Rovi's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorios Farmaceuticos Rovi E10 Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.89 24.43 27.46 41.15 42.52

Laboratorios Farmaceuticos Rovi Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.24 43.46 42.52 46.86 49.10

MEX:ROVIN vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Shiller PE Ratio falls into.


MEX:ROVIN
81GF Score
Laboratorios Farmaceuticos Rovi SA MEX:ROVIN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorios Farmaceuticos Rovi E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Laboratorios Farmaceuticos Rovi's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.479/131.3300*131.3300
=29.479

Current CPI (Jun. 2026) = 131.3300.

Laboratorios Farmaceuticos Rovi Quarterly Data

per share eps CPI Adj_EPS
201609 1.545 99.737 2.034
201612 2.018 101.842 2.602
201703 2.605 100.896 3.391
201706 3.864 101.848 4.983
201709 0.554 101.524 0.717
201712 0.104 102.975 0.133
201803 3.106 102.122 3.994
201806 0.331 104.165 0.417
201809 3.586 103.818 4.536
201812 0.905 104.193 1.141
201903 2.730 103.488 3.464
201906 3.631 104.612 4.558
201909 5.701 103.905 7.206
201912 3.251 105.015 4.066
202003 6.512 103.469 8.265
202006 7.355 104.254 9.265
202009 8.094 103.521 10.268
202012 6.217 104.456 7.816
202103 10.472 104.857 13.116
202106 11.768 107.102 14.430
202109 20.922 107.669 25.520
202112 22.894 111.298 27.015
202203 21.578 115.153 24.609
202206 10.986 118.044 12.222
202209 15.865 117.221 17.775
202212 30.824 117.650 34.408
202303 17.490 118.948 19.311
202306 6.678 120.278 7.292
202309 18.300 121.343 19.806
202312 36.096 121.300 39.081
202403 5.259 122.762 5.626
202406 11.329 124.409 11.959
202409 29.541 123.121 31.511
202412 39.528 124.753 41.612
202503 7.827 125.531 8.189
202506 9.186 127.251 9.480
202509 24.427 126.840 25.292
202512 17.592 128.400 17.993
202603 3.863 129.860 3.907
202606 29.479 131.330 29.479

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN49.10 mean?
Laboratorios Farmaceuticos Rovi (MEX:ROVIN) has a E10 of MXN49.10 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Laboratorios Farmaceuticos Rovi and its competitors.
Is Laboratorios Farmaceuticos Rovi's E10 too high?
Laboratorios Farmaceuticos Rovi's current E10 is MXN49.10. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's E10 compare to ZTS and UTHR?
Laboratorios Farmaceuticos Rovi's E10 of MXN49.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. Laboratorios Farmaceuticos Rovi's current E10 is MXN49.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Laboratorios Farmaceuticos Rovi (MEX:ROVIN) has a current E10 of MXN49.10. The stock's GF Value™ is MXN1,103.32, compared to a current price of MXN1,168.82 — trading 5.9% above its estimated fair value. The current E10 is MXN49.10. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (MEX:ROVIN), the current E10 is MXN49.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorios Farmaceuticos Rovi (MEX:ROVIN) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued. The current stock price of MXN1,168.82 is trading 5.9% above its estimated GF Value™ of MXN1,103.32.

Key valuation signals for MEX:ROVIN:

  • E10: MXN49.10
  • GF Value™: MXN1,103.32 vs. price of MXN1,168.82 (5.9% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the MEX:ROVIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorios Farmaceuticos Rovi Business Description

Address Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
81GF Score

Get the complete analysis for MEX:ROVIN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,168.82
Price
MXN1,103.32
GF Value